3PBIOVIAN

3PBIOVIAN

Private
SpainHealthcare & Life Scienceshttps://3pbiovian.com/

Last Round

M&A

Feb 1, 2024

Total Funding Raised

$8.04M

Company Overview

3PBIOVIAN is a biopharmaceuticals company that operates as a contract development and manufacturing organization (CDMO), delivering end-to-end services for biotech and pharma companies from early development to commercialization.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Pharma Supply Chain

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

contract development and manufacturing organizationCDMObiologics CDMOGMP manufacturingviral vector manufacturingplasmid DNA manufacturingcell therapyaseptic fill & finishAAV manufacturingdrug substance manufacturingdrug product manufacturingprotein productionprocess developmentfill and finishpDNA manufacturingconjugated biotherapeutics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

3PBIOVIAN Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

3PBIOVIAN Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
M&AFeb 1, 2024
Buyout/LBOJul 23, 2019
Growth EquityJul 23, 2014

Key People

Founding team and executive leadership

Antti Nieminen

Deputy CEO

Executive Team

Dámaso Molero Sánchez

Group Chief Executive Officer (CEO)

Executive Team

Heidi Suuronen

Group CFO

Executive Team

3PBIOVIAN Investors

Notable investors and investment history

InvestorRounds
Edmond de Rothschild Equity Strategies IVM&A
Infarco S.A.Growth Equity
Keensight CapitalBuyout/LBO, M&A
SodenaGrowth Equity, Buyout/LBO, M&A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 16, 2025

    Grew 16% QoQ, from 295 to 343 employees.

  • Jun 3, 2025

    Grew 28% QoQ, from 268 to 342 employees.

3PBIOVIAN Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

3PBIOVIAN Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about 3PBIOVIAN's valuation, stock price, and market status.

Firmographic Details

HeadquartersSpain
Employee Range354
Year Founded2024
Last FundingFeb 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.